Oxford biodynamics forecast
WebGet the latest Oxford Biodynamics PLC (OBD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebOur Oxford Biodynamics PLC stock forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. Assess the Oxford …
Oxford biodynamics forecast
Did you know?
WebBut as . Oxford BioDynamics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Show section WebOxford Biodynamics PLC Commercializing EpiSwitch ® 3D gene regulation for precision medicine Oxford Biodynamics' portfolio of clinical smart tests based on EpiSwitch® …
WebMar 29, 2024 · Oxford BioDynamics (LON:OBD) has a recorded net income of -£6.71 million. OBD has generated -GBX 0.06 earnings per share over the last four quarters. More Earnings Resources from MarketBeat WebFeb 25, 2024 · OXFORD, England, February 25, 2024--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for immune health based on its EpiSwitch 3D genomics ...
Web1 day ago · Oxford BioDynamics plc (OBD) is a United Kingdom-based biotechnology company. The Company is advancing personalized healthcare by developing and commercializing precision medicine tests for diseases, based on the Company’s three-dimensional (3D) genomics platform, EpiSwitch.
WebMar 21, 2024 · OXFORD BIODYNAMICS PLC : Financial Data Forecasts Estimates and Expectations OBD GB00BD5H8572 MarketScreener. Homepage. Equities. United …
WebApr 10, 2024 · Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers … hot and cold observablesWebNov 21, 2024 · OBD is the commercial pioneer and technological leader in isolating and analyzing 3D genomic biomarkers from a simple blood draw to guide treatment decisions, assess prognosis, and predict therapy... hot and cold numbers lotto maxWebAug 31, 2024 · Oxford BioDynamics Plc Jon Burrows, CEO Paul Stockdale, CFO Tel: +44 (0)1865 518910 Shore Capital - Nominated Adviser and Broker Advisory: Edward Mansfield / John More Broking: Fiona Conroy Tel ... hot and cold mist humidifierWebCompanies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period. psychotherapie krefeld hülsWebNov 2, 2024 · Dr. Jon Burrows, CEO of Oxford BioDynamics commented: “Working with an established integrated industry partner is another step on the path to commercializing our disease severity program for ... hot and cold observables rxjsWebJul 16, 2024 · Oxford BioDynamics (LON:OBD) has a market capitalization of £23.03 million and generates £176,000.00 in revenue each year. The biotechnology company earns £ … According to the Securities & Exchange Commission (SEC) insider trading “refers … Attempting to forecast things like market volatility is an imperfect task to say the … psychotherapie kongress 2022 berlinWebOxford BioDynamics plc (OBD) Ordinary 1p Shares Sell: 13.55p Buy: 14.95p 0.75p (5.56%) Market closed Prices as at close on 31 March 2024 Turn on streaming prices Add to watchlist Create an... hot and cold on youtube